{"id":"W4200103238","doi":"10.1200/jco.21.01546","title":"Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Venetoclax; Medicine; Azacitidine; Internal medicine; Minimal residual disease; Myeloid leukemia; Oncology; Complete remission; Gastroenterology; Multivariate analysis; Leukemia; Chemotherapy; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000792447,0.0001073981,0.0003531883,0.0001927476,0.0001458783,0.0003142345,0.0001528292,0.0002196795,0.0004628817],"category_scores_gemma":[0.001766645,0.00006721379,0.000181556,0.000233336,0.0002546575,0.0001968523,0.000137702,0.0003274122,0.00007840559],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002254871,"about_ca_system_score_gemma":0.0001680325,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005315337,"about_ca_topic_score_gemma":0.001123936,"domain_scores_codex":[0.9996132,0.0002061806,0.00002981959,0.00004890186,0.00006790367,0.00003403497],"domain_scores_gemma":[0.9988558,0.0004204387,0.000494052,0.00005733101,0.00003872173,0.000133643],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01098467,0.0003094288,0.9396831,0.00009380461,0.0001767698,0.0002622884,0.0001410652,0.001108385,0.007666755,0.00009225506,0.0001827365,0.03929888],"study_design_scores_gemma":[0.0005936461,0.007838499,0.9859714,0.00002770032,0.0001281919,0.001065891,0.00007566404,0.001830614,0.001460708,0.0001340491,0.0008612963,0.00001236887],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987578,0.0009328348,0.00006107368,0.00002938681,0.000002667042,0.000006487556,0.00003655989,0.000002468427,0.0001707296],"genre_scores_gemma":[0.9996077,0.0001445762,0.00007705614,0.00001851059,0.000009893491,0.000004517517,0.00008323662,4.73932e-7,0.00005410255],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.000792447,"threshold_uncertainty_score":0.004190922,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1011598271163015,"score_gpt":0.4356241830475861,"score_spread":0.3344643559312846,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}